senior notes offering
Sequencing Startup Singular Genomics Files for $100M IPO
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Illumina Prices $1B Senior Notes Offering
The sequencing instruments maker will use the proceeds to fund its planned acquisition of Grail and to pay related fees and expenses.
PerkinElmer to Offer $800M in Senior Notes
The firm plans to use $561 million of the net proceeds to fund the majority of its planned $591 million acquisition of Oxford Immunotec.
Agilent Prices $850M Senior Notes Offering
The firm plans to use the proceeds to fund the redemption of senior notes due in 2022 and for general corporate purposes.
Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary
The company plans to use the new funding, which will come from the sale of convertible senior notes due 2028, to support unspecified future growth initiatives.
Nov 17, 2020
Guardant Health Prices $1B Senior Notes Offering
Sep 30, 2020
Danaher Prices $1B Senior Notes Offering
Sep 28, 2020
Hologic Completes $950M Senior Notes Offering
Sep 15, 2020
Hologic Prices $950M Offering of Senior Notes
May 8, 2020
Luminex Prices $260M Senior Notes Offering
Apr 14, 2020
Natera Prices $250M Senior Notes Offering
Nov 20, 2019